Campion Suzanne 4

What Happened
Suzanne Campion, a director of Ardent Health, Inc. (ARDT), was granted 14,231 restricted stock units (RSUs) on April 1, 2026. The grant is reported as an award (code A) with an acquisition price of $0.00 (no cash paid). These RSUs are compensation, not an open-market purchase or sale.

Key Details

• Transaction date: April 1, 2026; Form 4 filed April 2, 2026 (timely filing).
• Grant: 14,231 RSUs; reported price $0.00; reported transaction value $0.
• Vesting: Per filing footnote, the RSUs vest in full on the first anniversary of April 1, 2026 (i.e., April 1, 2027), subject to continued service.
• Shares owned after transaction: not specified in the provided filing details.
• Filing status: Not indicated as late; filed the next day, within the usual Form 4 reporting window.

Context
These RSUs are equity compensation that will convert to actual shares only upon vesting (subject to service condition). Such awards are routine for executives and directors and do not represent an open-market buy or sale; they do not by themselves indicate a change in insider sentiment about the company.